Drug Formulary
Accreditation Canada Medication Management Standards require organizations to have an interdisciplinary committee responsible for managing medications. The Saskatchewan Health Authority (SHA) Drugs and Therapeutics Committee (DTC) is made up of 30 voting members representing many medical departments, disciplines and portfolios from across the province. DTC develops, implements, maintains and communicates the SHA Drug Formulary. Changes to the SHA Drug Formulary are communicated through the DTC Line Newsletter.
As the Drug Formulary is updated often, it is important to always refer back to this webpage for the most current version. The published date below the document indicates when it was last updated.
Drug Formulary
DTC Line Newsletters
DTC Line Newsletter Index
| Drug Name | Newsletter Edition(s) | Year |
|---|---|---|
abobotulinumtoxinA |
May 2021 |
|
acamprosate |
September 2021 | 2021 |
acetaminophen injection |
June 2021, September 2021, June 2024 | 2021/2024 |
acetylcysteine |
February 2023 | 2023 |
alteplase |
February 2023 | 2023 |
aminolevulinic acid |
April 2022 | 2022 |
amoxicillin/clavulanate injection |
April 2021 | 2021 |
anakinra |
October 2022 | 2022 |
baricitinib |
January 2022 | |
brilliant blue G |
November 2021 | 2021 |
budesonide/glycopyrrolate/formoterol inhaler (Breztri Aerosphere) |
February 2023 | 2023 |
buprenorphine extended-release subcutaneous injection |
April 2022, September 2024 | 2022, 2024 |
cabotegravir |
September 2022 | 2022 |
cabotegravir/rilpivirine (Cabenuva) |
September 2022 | 2022 |
carbetocin (Duratocin) |
March 2024 | 2024 |
chloroprocaine |
January 2022 | 2022 |
cinacalcet |
June 2023 | 2023 |
COVID-19 vaccine |
April 2021 | 2021 |
darbepoetin alfa |
January 2023 | 2023 |
desloratadine |
November 2022 | 2022 |
dimercaptopropane sulphate (DMPS) |
June 2024 | 2024 |
enoxaparin |
November 2021, January 2022, February 2022, April 2022, June 2022, LMWH Special Edition September 2022 | 2021/2022 |
EPINEPHrine metered dose inhaler (Primatene MIST) |
January 2021 | 2021 |
eptifibatide |
February 2023 | 2023 |
ethinyl estradiol/desogestrel (Mirvala) |
October 2022 | 2022 |
ferric derisomaltose/iron isomaltoside |
June 2021, September 2021, April 2023, April 2024 | 2021/2023/2024 |
ferric gluconate complex |
April 2023, April 2024 | 2023/2024 |
glucagon nasal powder (Baqsimi) |
June 2024 | 2024 |
glycerol phenylbutyrate (Ravicti) |
October 2024 | 2024 |
icosapent ethyl (Vascepa) |
September 2023 | 2023 |
idaruCIZUmab |
May 2021 | 2021 |
iloprost |
September 2022 | 2022 |
inFLIXimab, inFLIXimab biosimilars |
June 2022, September 2023 | 2022, 2023 |
indacaterol/glycopyrronium/mometasone furoate inhaler (Enerzair Breezhaler) |
September 2023 | 2023 |
indacaterol/mometasone furoate inhaler (Atectura Breezhaler) |
September 2023 | 2023 |
insulin aspart biosimilar (Trurapi) |
November 2022, Biosimilar Insulin Special Edition April 2023 | 2022/2023 |
insulin glargine biosimilar (Basaglar) |
November 2022, Biosimilar Insulin Special Edition April 2023 | 2022/2023 |
insulin lispro biosimilar (Admelog) |
November 2022, Biosimilar Insulin Special Edition April 2023 | 2022/2023 |
iron sucrose |
April 2023, April 2024 | 2023/2024 |
ketamine, intranasal racemic |
January 2022 | 2022 |
letermovir |
November 2021 | 2021 |
levETIRAcetam injection |
March 2021, June 2023 | 2021/2023 |
levonorgestrel intrauterine device (Mirena IUD) |
September 2021 | 2021 |
mifepristone (Mifegymiso) |
June 2022 | 2022 |
moxifloxacin ophthalmic solution (Sandoz-moxifloxacin; Vigamox) |
March 2024 | 2024 |
nirmatrelvir/ritonavir (Paxlovid) |
January 2022, April 2022 | 2022 |
nirsevimab (Beyfortus) |
October 2023 | 2023 |
nusinersen |
June 2022 | 2022 |
onasemnogene abeparvovec |
June 2022 | 2022 |
posaconazole |
September 2024 | 2024 |
prasugrel |
November 2021 | 2021 |
remdesivir |
February 2022, April 2022, January 2023 | 2022/2023 |
risdiplam |
June 2022 | 2022 |
riTUXimab, riTUXimab biosimilars |
May 2021, September 2023 | 2021, 2023 |
sarilumab |
January 2022 | 2022 |
semaglutide |
September 2021, April 2024 | 2021/2024 |
siltuximab |
October 2022 | 2022 |
sodium thiosulfate |
September 2024 | 2024 |
sotrovimab |
September 2021, January 2022, April 2022 | 2021/2022 |
succimer (Chemet) |
June 2024 | 2024 |
tacrolimus extended release (Envarsus PA) |
February 2022 | 2022 |
tenecteplase |
September 2022, February 2023 | 2022/2023 |
tinzaparin |
November 2021, January 2022, February 2022, April 2022, June 2022, LMWH Special Edition September 2022 | 2021/2022 |
tirofiban |
June 2022 | 2022 |
tocilizumab |
March 2021, September 2021, January 2022, October 2022 | 2021/2022 |
vancomycin |
April 2021 | 2021 |
vortioxetine |
May 2021 | 2021 |
Contact Information
SHA Drugs and Therapeutics Committee and Formulary Support Team
DTCSupport@saskhealthauthority.ca